| # | Title | Journal | Year | Citations |
|---|
| 1 | Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer | Journal of Clinical Oncology | 2020 | 158 |
| 2 | m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer | Theranostics | 2021 | 148 |
| 3 | Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy | Journal of Cellular and Molecular Medicine | 2019 | 106 |
| 4 | Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non–Small Cell Lung Cancers In Vitro and In Vivo | Clinical Cancer Research | 2016 | 83 |
| 5 | Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy | International Journal of Radiation Oncology Biology Physics | 2018 | 82 |
| 6 | Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis | PeerJ | 2018 | 74 |
| 7 | Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis | Targeted Oncology | 2016 | 73 |
| 8 | Nir1 promotes invasion of breast cancer cells by binding to chemokine (C–C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway | European Journal of Cancer | 2013 | 64 |
| 9 | Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC | Cancer Letters | 2018 | 61 |
| 10 | PET-Based Biodistribution and Radiation Dosimetry of Epidermal Growth Factor Receptor–Selective Tracer 11C-PD153035 in Humans | Journal of Nuclear Medicine | 2009 | 60 |
| 11 | Iodine-125-labeled cRGD-gold nanoparticles as tumor-targeted radiosensitizer and imaging agent | Nanoscale Research Letters | 2015 | 58 |
| 12 | Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma | Oncologist | 2021 | 56 |
| 13 | Mechanistic basis and clinical relevance of the role of transforming growth factor-β in cancer | Cancer Biology and Medicine | 2015 | 56 |
| 14 | Boschniakia Rossica Polysaccharide Triggers Laryngeal Carcinoma Cell Apoptosis by Regulating Expression of Bcl-2, Caspase-3, and P53 | Medical Science Monitor | 2017 | 54 |
| 15 | Advances in Molecular Mechanisms and Treatment of Radiation-Induced Pulmonary Fibrosis | Translational Oncology | 2019 | 54 |
| 16 | The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy | Radiotherapy and Oncology | 2020 | 54 |
| 17 | The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy | Radiotherapy and Oncology | 2019 | 50 |
| 18 | Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas | Medical Oncology | 2014 | 48 |
| 19 | Discriminating Ramos and Jurkat Cells with Image Textures from Diffraction Imaging Flow Cytometry Based on a Support Vector Machine | Current Bioinformatics | 2018 | 39 |
| 20 | miR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4 | Oncology Reports | 2016 | 37 |
| 21 | Programmed death‐ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor | Cancer Science | 2017 | 37 |
| 22 | Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis | Cancer Management and Research | 2018 | 35 |
| 23 | Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial | International Journal of Radiation Oncology Biology Physics | 2021 | 35 |
| 24 | Stereotactic body radiation therapy using the CyberKnife® system for patients with liver metastases | OncoTargets and Therapy | 2014 | 34 |
| 25 | Bone metastasis in patients with non-small cell lung cancer: The diagnostic role of F-18 FDG PET/CT | European Journal of Radiology | 2010 | 32 |
| 26 | MicroRNA-10b controls the metastasis and proliferation of colorectal cancer cells by regulating Krüppel-like factor 4 | Artificial Cells, Nanomedicine and Biotechnology | 2019 | 32 |
| 27 | Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines | Respiratory Research | 2019 | 31 |
| 28 | Radiation-induced heart disease in lung cancer radiotherapy | Medicine (United States) | 2016 | 29 |
| 29 | Automatic Lung Tumor Segmentation on PET/CT Images Using Fuzzy Markov Random Field Model | Computational and Mathematical Methods in Medicine | 2014 | 28 |
| 30 | Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy | Annals of Surgical Oncology | 2019 | 28 |
| 31 | Automatic segmentation and applicator reconstruction for CT‐based brachytherapy of cervical cancer using 3D convolutional neural networks | Journal of Applied Clinical Medical Physics | 2020 | 28 |
| 32 | Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer | Oncotarget | 2015 | 27 |
| 33 | Risk‐adapted stereotactic body radiation therapy for central and ultra‐central early‐stage inoperable non‐small cell lung cancer | Cancer Science | 2019 | 25 |
| 34 | Immune checkpoint inhibitors for esophageal squamous cell carcinoma: a narrative review | Annals of Translational Medicine | 2020 | 25 |
| 35 | Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC | Molecular Therapy - Nucleic Acids | 2021 | 25 |
| 36 | Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer | Radiation Oncology | 2018 | 24 |
| 37 | Tumor CD73/A2aR adenosine immunosuppressive axis and tumor‐infiltrating lymphocytes in diffuse large B‐cell lymphoma: correlations with clinicopathological characteristics and clinical outcome | International Journal of Cancer | 2019 | 24 |
| 38 | Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy | Clinical and Translational Radiation Oncology | 2019 | 24 |
| 39 | Silencing of ST6Gal I enhances colorectal cancer metastasis by down-regulating KAI1 via exosome-mediated exportation and thereby rescues integrin signaling | Carcinogenesis | 2016 | 23 |
| 40 | Feasibility and Efficacy of Concurrent Chemoradiotherapy in Elderly Patients with Esophageal Squamous Cell Carcinoma: a Respective Study of 116 Cases from a Single Institution | Asian Pacific Journal of Cancer Prevention | 2015 | 23 |
| 41 | Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma | International Journal of Radiation Oncology Biology Physics | 2019 | 22 |
| 42 | Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study | BMC Cancer | 2020 | 22 |
| 43 | Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized Trial | International Journal of Radiation Oncology Biology Physics | 2021 | 22 |
| 44 | Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials | Journal of Cancer Research and Clinical Oncology | 2020 | 21 |
| 45 | Diagnostic Value of18F-FDG PET/CT in Comparison to Bone Scintigraphy, CT and18F-FDG PET for the Detection of Bone Metastasis | Asian Pacific Journal of Cancer Prevention | 2013 | 21 |
| 46 | Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak | Lung Cancer | 2020 | 20 |
| 47 | Benefits of postoperative radiotherapy in multimodality treatment of resected small-cell lung cancer with lymph node metastasis | European Journal of Surgical Oncology | 2014 | 19 |
| 48 | Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes | OncoTargets and Therapy | 2016 | 18 |
| 49 | Pembrolizumab Combined With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Oesophageal Squamous Cell Carcinoma: Protocol for a Multicentre, Prospective, Randomized-Controlled, Phase III Clinical Study (Keystone-002) | Frontiers in Oncology | 2022 | 18 |
| 50 | Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer | OncoTargets and Therapy | 2015 | 17 |
